Abstract:BACKGROUND Rhinophyma, a late-stage subtype of rosacea, is characterized by excessive sebaceous glands and connective tissue proliferation. Patients may experience respiratory disturbances and psychological distress that significantly affect their quality of life when excessive nasal hyperplasia obstructs the external nasal valves. Surgery is the treatment of choice for rhinophyma. However, excessive bleeding, scarring, pigmentation, and high recurrence rates frequently characterize current surgical methods. AIM To evaluate the clinical effectiveness and recurrence rates after treating severe rhinophyma with the five-blade scratcher. METHODS This study retrospectively analyzed the clinical records of 28 patients with severe rhinophyma rosacea. The Global Flushing Severity Score (GFSS), Clinician Erythema Assessment (CEA), Rhinophyma Severity Index (RHISI), Glasgow Benefit Inventory (GBI), and satisfaction scores were used to assess the recovery of patients at 6 months and 5 years, with the recurrence rate calculated at 5 years postoperatively. In addition, the levels of pro-inflammatory factors (TNF-α, IL-1β, and IL-6) in the serum of patients before and after surgery were detected by ELISA. RESULTS The GFSS, CEA, and RHISI scores at 6 months and 5 years postoperatively were significantly lower than those preoperatively (P < 0.001 for both periods). Five-blade scratcher treatment greatly benefits patients as demonstrated by the GBI and patient satisfaction. A small number of patients (7/28, 25%) reported recurrence after surgical treatment for rhinophyma in our department that was not more serious than before treatment. The expression of pro-inflammatory factors (TNF-α, IL-1β, and IL-6) in the patient's serum was significantly reduced after surgery of five-blade scratcher. CONCLUSION The five-blade scratcher treatment demonstrates notable advantages, including simplicity, safety, efficacy, and cost-effectiveness, coupled with reduced bleeding, minimized scarring, lower recurrence rates, reduced the level of pro-inflammatory factors and improved patient satisfaction. Consequently, this therapeutic modality exhibits a viable option for individuals afflicted with severe rhinophyma.

Granulosis rubra nasi from plastic surgery perspective

Granulomatous Rosacea-Like Skin Rash: Extranodal Rosai-Dorfman Disease

[Nasal Coblation Plasma Surgery for the Treatment of Persistent Allergic Rhinitis: an Evaluation of Short-Term Outcomes].

Rhinophyma-A Case Report

Nasofacial Destruction Due to Rhinoscleroma and Review of Other Causes

Three-Dimensional M-Shaped Resection for Nasal Alar Hypertrophy in Asian Patients

Five-blade scratcher for treating severe rhinophyma: A retrospective study

A case of resistant granuloma faciale successfully treated with ablative fractional carbon dioxide laser

Nasal Tip and Alar Groove Plasty Through External Nasal Cutting in Asians: A Clinical Study

Effect of Nasal Skin Type on Skin Problems following Rhinoplasty

Schwannoma at an Unusual Site: Case Report and Surgical Technique Discussion for Nasal Dorsum

Granulomatosis With Polyangiitis (Wegener’s Granulomatosis) Nasal Reconstruction: Improved Outcomes With No Delay

Outcome Evaluation of Reconstructive Septorhinoplasty in Patients with a History of Nasal Skin Necrosis

Evaluation and management of facial granuloma caused by various injection materials

Pulmonary Foreign Body Granulomatosis after Cosmetic Injection

Characterization of Fat Used for the Optimization of the Soft Tissue Envelope of the Nose in Rhinoplasty

A Surgical Conundrum: Addressing a Large Nasal Defect Following Mohs Micrographic Surgery

Effect of Medical Ozone Therapy in Preventing Compromised Nasal Skin in Revision Rhinoplasty

Regression course of ostium granulomas under topical intranasal steroids coverage after endoscopic dacryocystorhinostomy

Rhinophyma in women: a case series

Majocchi's granuloma caused by Trichophyton rubrum after facial injection with hyaluronic acid: A case report